NovaBay Pharmaceuticals’ Neutrox® Product Line Receives CE Mark and ISO Certification for the European Union
Wednesday, September 14, 2016
NovaBay® Pharmaceuticals, Inc., a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene in the domestic eye care market, announces that its Neutrox® product line has received the CE mark, clearing the way for this product to be sold in European Union and certain other countries, and ISO 13485 certification, satisfying a critical step in European approval process.
“It’s gratifying to report that our Neutrox product line, which includes Avenova, has met the rigorous quality and safety standards to successfully complete the applications for both the CE mark and ISO certification,” said Mark M. Sieczkarek, NovaBay’s Chairman, President and CEO. “While we are committed to accelerating sales in the largely untapped U.S. market, these authorizations provide future opportunities to expand into significant new markets either through distributors or with our own sales organization.
“Avenova’s distinct advantages in managing chronic blepharitis are increasingly gaining recognition by eye care specialists both in the U.S. and abroad,” he added. “Avenova is the only eye care product based on our unique formulation of hypochlorous acid with no bleach impurities, and is the only commercial eye care product proven in a multicenter clinical study to substantially reduce bacteria that can cause blepharitis.”
Source : novabay.com
